Medical Economics July 23, 2024
House Oversight Committee takes aim at pharmacy benefit managers.
The three top pharmacy benefit managers (PBMs) are “raising prescription drug prices, undermining community pharmacies, and harming patients across the United States,” according to the U.S. House Committee on Oversight and Accountability.
On July 23, Committee Chair Rep. James Comer (R-Kentucky) published “The Role of Pharmacy Benefit Managers in Prescription Drug Markets,” a report ahead of a hearing with leaders of CVS Caremark, Express Scripts, and OptumRx. Those companies are the three largest PBMs of 66 operating in the United States; they control...
Today's Sponsors
Today's Sponsor